Key result
Streamlined ABC framework outlines patient-centered chronic coronary disease management across lifestyle and medical therapies.
Why the study?
The 2023 Multisociety Guideline updated recommendations for chronic coronary disease, prompting the need for a streamlined ABC mnemonic framework to apply Class One Recommendations and integrate updates into clinical practice.
This review provides busy clinicians with a succinct, focused mnemonic (ABC) to implement the latest evidence-based, Class I recommendations from the 2023 multisociety guidelines for chronic coronary disease.
Facilitates point-of-care adoption of 2023 CCD guidelines; leaves open whether the ABC framework improves outcomes in practice.
BACKGROUND: The 2023 Multisociety Guideline for the Management of Chronic Coronary Disease (CCD) updates recommendations for CCD, formerly known as "stable ischemic heart disease." This condition encompasses a spectrum of coronary vascular pathologies from subclinical to clinical ischemic heart disease. HYPOTHESIS: The new "ABC" mnemonic offers clinicians a streamlined framework for applying Class One Recommendations (COR1) and integrating recent updates into CCD management. METHODS: A critical analysis of the 2023 CCD guidelines was conducted, with this review highlighting key elements. RESULTS: The review outlines crucial changes, including novel recommendations supported by current clinical evidence. The focus is on these developments, clarifying their importance for day-to-day clinical practice. CONCLUSIONS: The review encourages a synergistic approach between primary healthcare providers and cardiologists to develop comprehensive strategies for lifestyle modification and medication therapy in CCD care. Furthermore, it suggests that utilizing comprehensive risk assessment tools can refine medical decision-making, ultimately enhancing patient care and clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Khorsandi et al. (2024) conducted a review in Chronic Coronary Disease (CCD). 2023 AHA/ACC/Multisociety Guideline for Chronic Coronary Disease was evaluated. The 2023 AHA/ACC/Multisociety Guideline for Chronic Coronary Disease provides a streamlined 'ABC' framework to implement comprehensive, patient-centered strategies for risk assessment, lifestyle modification, and targeted medication therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: